SightGlass Vision Surpasses Two Million Global Wearers of DOT Myopia Control Lenses

SightGlass Vision announced that its Diffusion Optics Technology (DOT) spectacle lenses for myopia control have surpassed two million wearers worldwide. This milestone was reached less than a year after the company passed one million users. The lenses utilize contrast-management technology to address childhood myopia. SightGlass also highlighted new clinical data from its CATHAY study in China, showing that DOT lenses slowed average myopia progression by 67% and axial length progression by 62% over two years compared to controls. CEO Andrew Sedgwick emphasized the trust placed in the product by eye care professionals, while commercial director Yuping Chen noted strong adoption among practitioners in China.